Intranasal Drug Delivery Device Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Drug delivery refers to the process of delivering a drug into the patient's body to have an effective therapeutic effect. Different modes are used for the delivery of the drug. Nasal and pulmonary routes are the most popular modes for delivering the drug. Intranasal delivery of drugs allows the drug to directly enter the brain by bypassing the BBB and avoids extensive hepatic and intestinal metabolism. This route has been a convenient and reliable route. Several new formulations are used to deliver drugs to the brain by olfactory, neuronal, and trigeminal pathways.

MARKET SCOPE

The Intranasal Drug Delivery Device Market is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Intranasal Drug Delivery Device Market with detailed market segmentation by type, material, end-user, and geography. The report provides key statistics on the market status of the leading Intranasal Drug Delivery Device Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•  Based on dosage form, the market is segmented into
  I. Sprays
  II. Drops & Liquids
  III. Powders
  IV. Gels
  
•  By system, the market is segmented into
  I. Multi-dose Systems
  II. Bi-dose Systems
  III. Unit-dose Systems
  
•  Based on containers, the market is segmented into Pressurized containers and Non-pressurized Containers.
  
•  On the basis of end-user, the market is segmented into Home Care Settings, Hospitals, and Others
  

MARKET DYNAMICS

Drivers:

•  Increase in patient's preference for the nasal drug.
  
•  Easy administration and better efficacy.
  

Restraints:

•  Complications associated with the overuse of nasal spray.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South And Central America. The Intranasal Drug Delivery Device Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South And Central America after evaluating political, economic, social and technological factors affecting the Intranasal Drug Delivery Device Market in these regions.

IMPACT OF COVID-19 ON INTRANASAL DRUG DELIVERY DEVICE MARKET

COVID-19 first began in Wuhan (China) in December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic has affected the growth of this market worldwide due to the business shutdown, worldwide lockdown, and supply and trade disruptions. While the situation is rapidly evolving, the pandemic had already disrupted the world in three ways the direct health impact the impact on the healthcare system, and the social and economic consequences of the pandemic. Patient visits to hospitals have been considerably reduced as a result of the lockdown in many nations. Surgeons do a battery of clinical tests before beginning interventional operations.

MARKET PLAYERS

The report covers key developments in the Intranasal Drug Delivery Device Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, partnerships & collaborations. These activities have paved the way for the expansion of the business and customer base of market players. The market players in the Intranasal Drug Delivery Device Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Intranasal Drug Delivery devices Market in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Intranasal Drug Delivery Device Market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, and the key development in the past five years.

•  Alza Corporation
  
•  AstraZeneca PLC.
  
•  Medimmune, Inc.,
  
•  Baxter International, Inc.
  
•  Becton
  
•  Dickinson and Company
  
•  GlaxoSmithKline Plc.
  
•  Johnson & Johnson
  
•  Aegis Therapeutics LLC
  
•  Novartis AG
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Intranasal Drug Delivery Device Report Scope